Amlodipine and stroke prevention [2]

Hypertension

Volumn 50, Issue 4, 2007, Pages

  Balligand, Jean Luc ^a   Godfraind, Theophile ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ARGININE; CALCIUM CHANNEL BLOCKING AGENT; CAVEOLIN 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1;

AORTA PRESSURE; DRUG MECHANISM; DRUG POTENTIATION; DRUG SELECTIVITY; ENZYME ACTIVATION; ENZYME ACTIVITY; HEART HEMODYNAMICS; LETTER; NONHUMAN; PRIORITY JOURNAL; SALT LOADING; STROKE; SYSTOLIC BLOOD PRESSURE; VASOCONSTRICTION;

AMLODIPINE; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CEREBROVASCULAR ACCIDENT; CIRCADIAN RHYTHM; HUMANS; HYPERTENSION; MYOCARDIAL INFARCTION; TUNICA INTIMA; VASODILATION;

EID: 34548854782     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.107.096610     Document Type: Letter

References (5)

1. Wang JG, Li Y, Franklin SS, Safar M. Prevention of stroke and myocardial infarction by amlodipine and angiotensin receptor blockers. A quantitative overview. Hypertension. 2007;50:181-188.
2. Godfraind T. Calcium Channel Blockers. Basel, Switzerland: Birkhaäuser Verlag; 2004.
3. Godfraind T. Antioxidant effects and the therapeutic mode of action of calcium channel blockers in hypertension and atherosclerosis. Philos Trans R Soc Lond B Biol Sci. 2005;360:2259-2272.
4. Batova S, DeWever J, Godfraind T, Balligand JL, Dessy C, Feron O. The calcium channel blocker amlodipine promotes the unclamping of eNOS from caveolin in endothelial cells. Cardiovasc Res. 2006;71:478-485.
5. Miao CY, Xie HH, Zhan LS, Su DF. Blood pressure variability is more important than blood pressure level in determination of end-organ damage in rats. J Hypertens. 2006;24:1125-1135.